Dr. Royal Edward Dean, MD

Dr. Dean practices at Royal E Dean MD Medical Corporation in Simi Valley, California.

Dr. Dean's NPI, 1417976945, was assigned on July 18, 2006. Dr. Dean graduated from Oral Roberts University School of Medicine in 1987. Dr. Dean holds California license G063880.

Dr. Dean's primary practice is Royal E Dean MD Medical Corporation, at 1129 Red Tail Way, Simi Valley, CA 93065 in Ventura County. The practice phone is (805) 577-1515.

Dr. Dean's primary practice is Royal E Dean MD Medical Corporation in Simi Valley, California. Dr. Dean is also affiliated with Adventist Health Simi Valley. Dmand AI also links Dr. Dean to 1 more hospital, 4 home health agencies, 1 physician office and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 8 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Dean is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dean is licensed in California.

Dmand AI lists acid reflux, acute respiratory failure, acute skin infection, ADHD, anxiety, arteritis, arthritis and asthma among the conditions Dr. Dean treats.

CMS data shows 2,565 Medicare services from Dr. Dean across 16 procedure codes in 2024, for 430 Medicare patients. Medicare paid $233,432 for them. Every service was in an office.

CMS counts 430 Medicare patients who saw Dr. Dean in 2024. The largest group is 65 to 74, with 208 patients. 74% of them have high cholesterol, and 62% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 70, with 58% women.

In 2024, Dr. Dean wrote 8,451 Medicare Part D claims for 442 patients. 85% of them were for generic drugs. CMS names the drug for 7,591 of them, across 148 drugs with 11 or more claims each, at $550,072 in total drug cost. In 2023, CMS named 7,717 claims across 153 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Dean for performance year 2024, reported through an alternative payment model (APM). Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dean as offering telehealth. CMS counts 23 procedures of removal of skin lesions by Dr. Dean, more than 66% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 66 general payments to Dr. Dean from 17 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $383.

Dmand AI lists 2 awards for Dr. Dean, most recently CMS Stage 1 EHR in 2013.

Dr. Dean graduated from Oral Roberts University School of Medicine in 1987.

Dr. Dean is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.